Bionano Genomics (BNGO)
(Delayed Data from NSDQ)
$0.79 USD
+0.03 (3.57%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.78 -0.01 (-0.78%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth D Momentum D VGM
Cash flow Statements
Fiscal Year End for Bionano Genomics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -232.49 | -132.60 | -72.44 | -41.11 | -29.82 |
Depreciation/Amortization & Depletion | 90.65 | 10.48 | 3.70 | 1.48 | 1.13 |
Net Change from Assets/Liabilities | -14.77 | -28.59 | -7.65 | -3.44 | -4.97 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 31.43 | 25.89 | 4.46 | 4.75 | 4.13 |
Net Cash From Operating Activities | -125.18 | -124.82 | -71.93 | -38.31 | -29.53 |
Property & Equipment | -1.69 | -2.38 | -0.82 | 0.00 | -0.06 |
Acquisition/ Disposition of Subsidiaries | 0.10 | -30.65 | -49.09 | -2.45 | 0.00 |
Investments | 25.75 | 116.69 | -226.91 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | -0.89 | -1.25 | 0.00 | 0.00 |
Net Cash from Investing Activities | 24.16 | 82.77 | -278.06 | -2.45 | -0.06 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 57.83 | 23.62 | 352.82 | 68.63 | 20.56 |
Issuance (Repayment) of Debt | 70.95 | -0.04 | -15.01 | -3.23 | 8.32 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | -1.50 | 1.50 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -14.97 | -0.58 | -1.70 | -2.00 | 0.00 |
Net Cash from Financing Activities | 113.82 | 23.01 | 336.11 | 61.90 | 30.38 |
Effect of Exchange Rate Changes | 0.07 | -0.04 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 12.86 | -19.08 | -13.88 | 21.14 | 0.79 |
Cash at Beginning of Period | 5.49 | 24.57 | 38.45 | 17.31 | 16.52 |
Cash at End of Period | 18.35 | 5.49 | 24.57 | 38.45 | 17.31 |
Diluted Net EPS | -6.81 | -4.60 | -2.60 | -3.90 | -19.90 |
Fiscal Year End for Bionano Genomics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -232.49 | -188.60 | -76.04 | -37.12 |
Depreciation/Amortization & Depletion | NA | 90.65 | 87.24 | 6.36 | 3.16 |
Net Change from Assets/Liabilities | NA | -14.77 | -8.52 | -9.60 | -3.33 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 31.43 | 14.48 | 10.16 | 4.88 |
Net Cash From Operating Activities | NA | -125.18 | -95.40 | -69.11 | -32.41 |
Property & Equipment | NA | -1.69 | -0.95 | -0.84 | -0.36 |
Acquisition/ Disposition of Subsidiaries | NA | 0.10 | 0.10 | 0.10 | 0.00 |
Investments | NA | 25.75 | 80.38 | 46.88 | 16.89 |
Other Investing Activities | NA | 0.00 | 0.00 | -0.03 | 0.00 |
Net Cash from Investing Activities | NA | 24.16 | 79.53 | 46.10 | 16.53 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 57.83 | 46.53 | 33.60 | 15.25 |
Issuance (Repayment) of Debt | NA | 70.95 | -0.03 | -0.02 | -0.01 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -14.97 | -1.16 | -0.84 | -0.38 |
Net Cash from Financing Activities | NA | 113.82 | 45.33 | 32.74 | 14.86 |
Effect of Exchange Rate Changes | NA | 0.07 | 0.02 | 0.03 | 0.04 |
Net Change In Cash & Equivalents | NA | 12.86 | 29.48 | 9.77 | -0.99 |
Cash at Beginning of Period | NA | 5.49 | 5.49 | 5.49 | 5.49 |
Cash at End of Period | NA | 18.35 | 34.97 | 15.26 | 4.50 |
Diluted Net EPS | NA | -1.15 | -3.22 | -1.24 | -1.20 |